Table 7:
CC | MICE | SIPW | |
---|---|---|---|
CSHRa (p-Value) | CSHRa (p-Value) | CSHRa (p-Value) | |
Time on ART (per six months) | 1.19 (<0.001) | 1.24 (<0.001) | 1.19 (<0.001) |
Gender | |||
Female & non-pregnant | 1.00 (−) | 1.00 (−) | 1.00 (−) |
Female & pregnant | 1.14 (0.204) | 1.41 (0.017) | 1.14 (0.182) |
Male | 1.08 (0.274) | 1.16 (0.011) | 1.15 (0.080) |
Ageb (per 10 years) | 1.06 (0.140) | 1.07 (0.012) | 1.09 (0.060) |
CD4b (per 100 cell/μL) | 0.98 (0.422) | 1.00 (0.633) | 0.99 (0.535) |
HIV status disclosed | 1.01 (0.939) | 1.03 (0.754) | 1.01 (0.936) |
Travel time to clinic >30′ | 0.81 (0.005) | 0.91 (0.001) | 0.81 (0.008) |
Level of care | |||
Secondary/Tertiary | 1.00 (−) | 1.00 (−) | 1.00 (−) |
Primary | 1.37 (<0.001) | 1.09 (0.263) | 1.28 (0.003) |
Cause-specific hazard ratio.
At ART initiation.